Systemic Sclerosis
Hypothesis-driven treatment strategies for systemic sclerosis are outlined
Published in Medical Letter on the CDC and FDA, July 23rd, 2006
According to their report, "We review data from controlled trials and randomized controlled trials to examine the hypothesis for the pathogenesis of systemic sclerosis. Strategies used to treat the vascular complications in systemic sclerosis have so far shown the biggest successes, especially in the management of renal crisis and pulmonary arterial hypertension. Because these drugs have improved function and quality of life and have increased survival rates, they can truly be classified as disease-modifying compounds."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Anthrax Vaccine
Immunochromatographic device to measure anti-anthrax protective antigen IgG is developed - Drug Development
Global perspective on advisory process for anticancer drug regulation are outlined - Epilepsy
Attitudes about epilepsy components of U.S. Centers for Disease Control and Prevention epilepsy instrument have been validated - Respiratory Syncytial Virus
Alpha and lambda interferon suppress CD4 T cells induced by respiratory syncytial virus - Allergy Medicine
House dust extracts have both Th2 adjuvant and tolerogenic activities - Avian Influenza
Sinovac reports positive phase 1 preliminary trial results on bird flu vaccine - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
